Zomedica Corp.

ZOMDF Biotech & pharma

Develops diagnostic devices for veterinarians to treat dogs, cats, and horses.

Jun 2026Revenue $36.9M/yrExpenses $57.6M/yr
No trendCash runway ≈ 6 months from Jun 2026
Figures by year

When will Zomedica be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $36.9M and expenses $57.6M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$32.0M$116M−$84.4M
Dec 2024$27.3M$78.3M−$51.1M
Dec 2023$25.2M$68.5M−$43.3M
Dec 2022$18.9M$40.9M−$21.9M
Dec 2021$4.13M$25.5M−$21.4M
Dec 2020$0.00$16.8M−$16.8M